The Parkland Health Foundation is thrilled to announce a generous philanthropic investment of $500,000 from the McKesson Foundation, dedicated to advancing colorectal cancer care for Parkland patients.
The funding is earmarked to facilitate the adoption of flexible sigmoidoscopy, a less-invasive and quicker alternative to traditional colonoscopies, for the benefit of Parkland patients.
Umber Dickerson, Administrative Director of Global Cancer Programs at Parkland Health, emphasized the significance of flexible sigmoidoscopy in the screening, assessment, and treatment of colorectal cancer. "With this new technology, we can provide the best possible care to our patients and ensure their continued comfort and quality of life," Dickerson stated.
According to the 2022 Dallas County Community Health Needs Assessment, cancer ranks as the second leading cause of death in Dallas County. Nationally, colorectal cancer stands as the second most common cause of cancer-related deaths. Disturbingly, the American Cancer Society notes that Black Americans face higher risks, with rates 20% more likely and a 40% higher likelihood of mortality compared to other racial/ethnic groups.
The McKesson Foundation's commitment extends beyond this recent investment. In 2022, the foundation granted $500,000 to Parkland’s C.V. Roman Health Center in RedBird Dallas, aiming to broaden healthcare access for residents in southern Dallas County.
Nimesh Jhaveri, a director of the McKesson Foundation, highlighted their dedication to dismantling socioeconomic barriers to quality healthcare for vulnerable communities. "We are excited to continue our partnership with Parkland Health and the Parkland Health Foundation as we address barriers in Dallas County and help reduce the burden of cancer in our community," said Jhaveri.
As the McKesson Foundation marks 80 years of impact, Michael Horne, President and CEO of Parkland Health Foundation, expressed gratitude for the partnership. "It’s amazing to have such a strong partner helping provide a more efficient way to detect colon cancer and ultimately, save lives."
